Evidence map›Paper›PMID 36261234›Full record

ArticleBMJ open2022

Characterising methamphetamine use to inform health and social policies in Manitoba, Canada: a protocol for a retrospective cohort study using linked administrative data.

Nathan C Nickel, Jennifer E Enns, Amy Freier, Scott C McCulloch, Mariette Chartier, Hera J M Casidsid, Oludolapo Deborah Balogun, Drew Mulhall, Roxana Dragan, Joykrishna Sarkar and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Nathan C NickelDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada nathan.nickel@umanitoba.ca.ORCID 0000-0001-5836-5297
Jennifer E EnnsManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.
Amy FreierManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.
Scott C McCullochManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0003-4533-4947
Mariette ChartierManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.
Hera J M CasidsidManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.
Oludolapo Deborah BalogunManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.
Drew MulhallDepartment of Orthopedic Surgery, University of Manitoba, Winnipeg, Manitoba, Canada.
Roxana DraganManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.
Joykrishna SarkarManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.
James BoltonDepartment of Psychiatry, University of Manitoba, Winnipeg, Manitoba, Canada.
Geoffrey KonradDepartment of Psychiatry, University of Manitoba, Winnipeg, Manitoba, Canada.
Wanda Phillips-BeckFirst Nations Health and Social Secretariat of Manitoba, Winnipeg, Manitoba, Canada.
Julianne SanguinsManitoba Métis Federation, Winnipeg, Manitoba, Canada.
Carolyn ShimminGeorge and Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba, Canada.
Neil McDonaldWinnipeg Fire Paramedic Service, Winnipeg, Manitoba, Canada.
Javier MignoneDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Aynslie HindsDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Methamphetamine Use In Manitoba Research Team
Manitoba Health · CAUniversity of Manitoba · CAFirst Nations Health and Social Secretariat of Manitoba · CAGeorge & Fay Yee Centre for Healthcare Innovation · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRising use of methamphetamine is causing significant public health concern in Canada. The biological and behavioural effects of methamphetamine range from wakefulness, vigour and euphoria to adverse physical health outcomes like myocardial infarction, haemorrhagic stroke, arrhythmia and seizure. It can also cause severe psychological complications such as psychosis. National survey data point to increasing rates of methamphetamine use, as well as increasing ease of access and serious methamphetamine-related harms. There is an urgent need for evidence to address knowledge gaps, provide direction to harm reduction and treatment efforts and inform health and social policies for people using methamphetamine. This protocol describes a study that aims to address this need for evidence.

methodsThe study will use linked, whole population, de-identified administrative data from the Manitoba Population Research Data Repository. The cohort will include individuals in the city of Winnipeg, Manitoba, who came into contact with the health system for reasons related to methamphetamine use from 2013 to 2021 and a comparison group matched on age, sex and geography. We will describe the cohort's sociodemographic characteristics, calculate incidence and prevalence of mental disorders associated with methamphetamine use and examine rates of health and social service use. We will evaluate the use of olanzapine pharmacotherapy in reducing adverse emergency department outcomes. In partnership with Indigenous co-investigators, outcomes will be stratified by First Nations and Métis identity. ETHICS AND DISSEMINATION: The study was approved by the University of Manitoba Health Research Ethics Board, and access datasets have been granted by all data providers. We also received approval from the First Nations Health and Social Secretariat of Manitoba's Health Information Research Governance Committee and the Manitoba Métis Federation. Dissemination will be guided by an 'Evidence 2 Action' group of public rightsholders, service providers and knowledge users who will ensure that the analyses address the critical issues.

Indexed as

MethamphetamineCanadaCohort StudiesHumansManitobaOlanzapinePublic PolicyRetrospective StudiesMethamphetamineOlanzapineepidemiologymental healthsubstance misuse

Identifiers

PMID36261234
PMCPMC9582321
OpenAlexW4306812109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.